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Introduction: The data from our randomized controlled trial suggested that 12-week Remedial Yoga
Module (RYM) was efﬁcacious in improving the symptoms of Irritable Bowel Syndrome (IBS). Following
on from the initial study, RYM was provided to the Wait-list group, (WL-Yoga), at the end of trial period.
All intervention groups were further provided with an additional 12 weeks support to determine the
impact of maintaining the intervention.
Methods: Wait [188_TD$DIFF]-list Control group (WL-Yoga) from our previous 12-week Yoga intervention study was
offered the same 12-week (one hour sessions, three times aweek) RYMpractices aswas given to Yoga and
Combination groups. Participants completing 12-week RYM intervention from all groupswere combined
into one Follow-up group (n =28) and were offered an additional 12 weeks [189_TD$DIFF]of once a week, one hour
supervised maintenance RYM intervention.
Results: 12-week intervention of RYM in the WL-Yoga group showed similar improvements of IBS
symptoms as observed in Yoga and Combination groups [190_TD$DIFF]in the previous study. All the signiﬁcant
improvements observed at week 12 were sustained at week 24 [191_TD$DIFF]in the follow-up group with signiﬁcant
further improvements in IBS-SS scores (p<0.01), IBS-GAI (p<0.05), right and left shoulder ﬂexibility
(p<0.05), handgrip strength (p<0.001), accuracy in mental arithmetic task (p<0.05), decreased LF
(p<0.05), and increased HF (p<0.05).
Conclusion: Efﬁcacy of RYM for IBS is replicable, and the improvements were sustained/enhanced with a
maintenance intervention. RYM alone or RYM within conventional care, as implemented in the present
study, could be a safe and effective long-term solution for IBS symptoms.
Trial registration: ISRCTN, 42102754.
ã 2015 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
To date, Irritable Bowel Syndrome (IBS) remains a complex
disorder to diagnose and treat. In the recent past,anda Yoga Research Founda-
USA.
vuri),
ail.com (A. Tabesh),
gmail.com (S.R. Selvan).
Farina Street, Norwalk, CA
avez Ave, #100, Los Angeles,
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r GmbH. This is an open access apharmacotherapy in conjunction with complementary and alter-
native medicine therapies, such as probiotics, acupuncture, and
Yoga, have been recommended to better manage the primary and
secondary symptoms of IBS [1,2]. The initial randomized controlled
trial reported that 12-week Remedial Yoga Module remarkably
improved the symptoms in irritable bowel syndrome patients
(Phase 1). RYM emphasizes tools drawn from the traditional
discipline of Yoga, such as breathing, loosening the body, simple
postures, regulated controlled breathing, and meditation [3].
In Phase 2 of the study we investigated: (1) whether we could
replicate the effects of RYM on the Wait-list Control group from
the previous study (Phase 1) and (2) if once a week monitored
Yoga session (one hour of RYM) for 12 more weeks can sustain or
further enhance those improvements observed during the ﬁrst
12 weeks.rticle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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2.1. Participants
2.1.1. Wait list-Yoga group
Twenty seven patients randomized to the Wait-list Control
group completed the 12 week waiting period as reported in our
previous study (Phase 1). All the patients in this groupwere invited
to participate in the RYM intervention program of three times a
week for 12 weeks. They were allowed to be on their medications/
supplements for IBS symptoms during the Yoga intervention.
Seven patients were able to complete the 12 week RYM
intervention. After the completion, these seven patients (referred
to as WL-Yoga group) were offered once a week maintenance
session for 12 more weeks.
2.1.2. Follow-up group
A total of 28 IBS patients, 24 females and 4 males from
Phase 1 volunteered for the maintenance intervention study.
The sample consisted of 11 patients from the Yoga group, 10
from combination group, and 7 from WL-Yoga group. The
subjects from all three groups, (those who have completed 12
weeks of RYM intervention) were combined into one group,
referred to as the “Follow-up group,” and were administered
once a week, one hour monitored RYM sessions. The inclusion
criterion for the follow-up group was the completion of 12-
week RYM intervention, and the only exclusion criterion was
that there should not be any Yoga practice at home during the
12 week follow-up period.
2.2. Study design and procedure
Protocol of this study was approved by White Memorial
Medical Center Institutional Review Board, Los Angeles, California,
USA and the Institutional Ethics Committee of Swami Vivekananda
Yoga University (SVYASA) Bangalore, India.
Outcomes were measured twice for the subjects in WL-Yoga
group—at the end of 12 week RYM intervention and at the end of
week 24 as a part of the Follow-up group. The other subjects in the
Follow-up group were appraised only once, at the end of week 24.
The methodology and procedures used for assessments are
described in detail in our previous study (Phase 1). A brief
description is given below.
2.3. Primary outcome assessments
IBS-SSS: IBS- [211_TD$DIFF]Symptom Severity Scale (IBS-SSS) is a self-reported
visual analog scale questionnaire regarding the severity of the
symptoms [4]. The score for each of the ﬁve questions ranges
from 0 to 100 with a higher score indicating severity of the
symptoms.
IBS-QOL: Irritable bowel syndrome quality of life (IBS-QOL) is a
self-reported tool designed to assess various aspects of quality of
life in IBS patients [5]. The questionnaire consists of a [212_TD$DIFF]ﬁve point
rating of 34 items. High score reﬂects improved quality of life.
2.4. Secondary outcome assessments
Secondary outcome assessments were HADS, IBS-GAI, auto-
nomic symptom score, medicine and supplement use, BMI and
physical ﬂexibility, autonomic function tests of sympathetic
reactivity (hand grip and mental arithmetic tasks), and
parasympathetic reactivity (measured in deep breathing and
supine to upright posture). Details of these assessments are in
Phase 1.2.5. Demographic and clinical variables
Information about standard demographic and clinical variables
such as age, education, employment, marital status, and years
since diagnosis was reported in our previous study (Phase 1).
[215_TD$DIFF] .6. Data analyses and statistics
The analyses were carried out to evaluate two aspects of the
study. The ﬁrst aimwas to evaluate replication of improvements in
the WL-Yoga group, as previously reported in Yoga and Combina-
tion groups. Paired samples t-test was performed to analyze the
pre- and post-effect of RYM intervention on WL-Yoga subjects. In
Phase 1, we reported that there were no differences between Yoga
and Combination groups at the end of 12 week RYM intervention.
One way ANOVA tests were performed to assess if any differences
existed (after intervention) in the improvements between Yoga,
Combination, and WL-Yoga groups.
[220_TD$DIFF] he second aim was to evaluate whether the 12-week
“maintenance” RYM intervention had sustained improvements
(from the improvements seen in all three groups at end of 12 week
RYM intervention) on a [222_TD$DIFF]follow-up group. All 28 patients completed
the initial 12-week intervention and 12 weeks of maintenance
intervention (week 24measurements). Repeatedmeasures ANOVA
was used to analyze changes fromweek 0 toweek 12 and week 24.
This allowed us to compare changes from week 0 to week 24 [224_TD$DIFF]and
compare maintenance or regression of improvements from week
12 to week 24. The nominal data of medicine and supplement use
was analyzed using McNemar’s test. All the analysis was done
using SPSS (Statistical Package for the Social Sciences, IBM
Corporation, NY, version 20.0) software.
3. Results
3.1. Post-12 week RYM intervention in Wait-list (WL-Yoga) group
The 27 patients, who comprised theWait-list group from Phase
1 study were offered the RYM intervention. Seven patients could
not attend the [227_TD$DIFF]Yoga intervention, due mostly to work schedule
changes. A total of 20 patients were able to start the Yoga
intervention. After a few weeks of Yoga intervention, 13 patients
had dropped out either due to interference with their family-
children’s activities (4), work-related problems [229_TD$DIFF](3), ﬁnding the
Yoga sessions difﬁcult (4), or pregnancy. Fig. 1 illustrates the ﬂow
chart of patients from the start of the study through the 3 month
follow-up.
Seven patients completed the 12 week RYM intervention. Even
though, three RYM sessions per week [230_TD$DIFF]for 12 weeks were offered,
subjects of the WL-Yoga group attended [231_TD$DIFF]an average 23 sessions
(64%). Week [232_TD$DIFF]12 data (before starting Yoga intervention) of the
seven patients was considered as baseline data for the WL-Yoga
group. Data was conﬁrmed to be normal by Shapiro Wilke’s test.
Paired samples t-test revealed the efﬁcacy of Yoga intervention on
the WL-Yoga subjects. In the primary outcome assessments of IBS-
SS scores (Table 1), a 56% reduction in [233_TD$DIFF]severity of symptoms
(p<0.001) and a 45% improvement in the QOL (p<0.01) was
observed. The secondary outcome assessments of HADS (p<0.01),
autonomic symptom score (p<0.01), [234_TD$DIFF]and IBS-GAI (p<0.001) have
all shown signiﬁcant improvements with 12 weeks of RYM
intervention (Table 1). Similarly, there was a signiﬁcant improve-
ment (p< [237_TD$DIFF]0.05) regarding medicine and supplement use-four
patients reported reduced usage of [238_TD$DIFF]medication/supplements, one
patient was using the same dosage, and two patients were not
using any medications/supplements for the relief of IBS symptoms
at baseline.
[(Fig._1)TD$FIG]
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Fig. 1. Flow chart of patients—randomization to completion of maintenance intervention.
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(handgrip and mental arithmetic tasks) showed no changes in
blood pressure or [240_TD$DIFF]heart rate after 12 weeks of intervention. [241_TD$DIFF]
However, a signiﬁcant improvement in the handgrip strength
(p<0.01) was observed ([242_TD$DIFF]data not shown). In the parasympathetic
tasks of deep breathing and supine to upright position (30:15), no
signiﬁcant changes were observed when compared to baseline
values (data not shown).
We reported that after 12 weeks of RYM intervention, there
were no differences between Yoga and Combination groups [243_TD$DIFF]andTable 1
Comparison of primary and secondary outcomes in WL-Yoga group at week 12 with w
Assessments Week 0 Week 12
Primary outcomes
IBS-SSS 26654.22 117.8674.73***
IBS-QOL 100.7127.23 146.1414.67** (
Secondary outcomes
HADS-A 11.294.46 6.142.34** (42.
HADS-D 8.143.02 4.712.22** (42
ANS-SS 4.571.72 2.431.72** (46.
IBS-GAI 2.71 .49 6.14 .69*** (126
Data were analyzed using paired samples t test; values are means SD.
(%): Percentage change when compared to week 0. [181_TD$DIFF]*: Represents change from week 0that they had both improved similarly. To assess if there were any
post-intervention differences between all three groups (Yoga,
Combination and WL-Yoga), the data (Yoga, n =25; Combination,
n =26; and WL-Yoga, n =7) was analyzed using one way ANOVA
followed by post hoc analysis with Bonferroni correction. The
results revealed no signiﬁcant differences between groups in the
primary outcome assessments of IBS-SSS and IBS-QOL (Fig. 2a [200_TD$DIFF]) and
secondary outcome assesments of HADS and autonomic symptom
score. In [246_TD$DIFF]the assessment of IBS-GAI, WL-Yoga group showed less
improvement [247_TD$DIFF]than the Yoga group (p< [248_TD$DIFF]0.05), and there were no [249_TD$DIFF]eek 0.
Change (95% CI) t-Value
(55.69%) 148.14 [180_TD$DIFF](97.58, 198.58) 7.169
45.11%) 45.43 (68.54, 22.31) 4.81
96%) 5.14 (2.25, 8.04) 4.34
.14%) 3.43 (1.75, 5.11) 5
83%) 2.14 (1.15, 3.13) 5.3
.56%) 3.43 (4.33, 2.53) 9.3
to week 12; **p<0.01; ***p<0.001.
[(Fig._2)TD$FIG]
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Fig. 2. Comparison of between group differences in primary and secondary outcome measures, in IBS patients (Yoga, Combination andWL-Yoga groups) after 12-week RYM
intervention. (a) [173_TD$DIFF] BS-SS scores and IBS-QOL in IBS patients (Yoga, Combination and WL-Yoga groups) after 12-week RYM intervention. (b) HADS-anxiety, HADS-depression,
autonomic symptom score, and IBS-Global Assessment of Improvement. Data were analyzed using one way ANOVA followed by Post hoc [174_TD$DIFF]analysis with Bonferroni correction;
*: Represents signiﬁcant difference between Yoga and WL-Yoga group; *p<0.05.
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The improvements observed with medicine and supplement
use in WL-Yoga group were signiﬁcantly less compared to both
Yoga (p<0.01) and Combination (p<0.05) groups (data not
shown).
3.2. Follow-up group
3.2.1. Subjects
Among the 58 patients (25 in Yoga, 26 in Combination[219_TD$DIFF], and 7 in
WL-Yoga groups) that completed the RYM intervention [results of
Yoga and Combination groups reported in Phase 1], 28 patients
have completed all 24 weeks of intervention and were considered
for per protocol analysis. Subjects comprised of IBS-C (n =8,
median age 46.5 years; 28.6% of total completed), IBS-D (n =10,
median age 46 years; 35.7% of total completed), and IBS-M (n =10,
median age 47.5 years; 35.7% of total completed). The median
duration of IBS from diagnosis [252_TD$DIFF]to enrolling in this clinical trial was
ﬁve years and medications used was one year. Table 2 depicts the
characteristics of the 28 patients that volunteered for the 12 week
follow up.3.2.2. Per-protocol analysis.
Repeated measures ANOVA were performed for each assess-
ment with one factor, time point (week 0, week 12 and week 24).
Signiﬁcant main effects and interaction between time points and
assessments are given in Supplement Table 1.
3.3. Primary outcome assessments—IBS-SSS and IBS-QOL
Post hoc analysis with Bonferroni correction of IBS-Symptom
severity scale and Quality of Life score showed signiﬁcant
improvements at week 12 (p<0.001) and were maintained at
week 24 (p<0.001), when compared to week 0. Furthermore,
there was a signiﬁcant reduction in IBS- [256_TD$DIFF]SSS at week 24 (28%;
p<0.01) when compared to week 12 (Fig. 3).
A detailed analysis of the ﬁve sub-scales of IBS-SSS and eight
dimensions of IBS-QOL showed no regression of improvements
from week 12 to week 24. In fact, there were signiﬁcant further
improvements observed in two sub-scales of IBS-SSS, severity of
pain (p<0.05) and interference with life in general (p< [257_TD$DIFF]0.05), and
body image dimension of IBS-QOL (p<0.01) (Supplement Table 2a
and b).
Table 2
Characteristics of follow-up group subjects completing the 12 week maintenance program.
Total (28) Yoga group (11) Combination group (10) Wait-list Yoga group (7)
Marital status
Married/cohabitant 15 (53.7%) 8 (72.7%) 4 (40%) 3 (42.9%)
Single 11 (39.3%) 3 (27.3%) 5 (50%) 3 (42.9%)
Divorced 2 (7.1%) 0 1 (10%) 1 (14.2%)
Ethnicity
Hispanic 20 (71.4%) 6 (54.5%) 8 (80%) 6 (85.7%)
Non-hispanic 8 (28.6%) 5 (45.5%) 2 (20%) 1 (14.3%)
Education
Middle school 3 (10.7%) 1 (9.1%) 1 (10%) 1 (14.3%)
High school 12 (42.9%) 4 (36.4%) 4 (40%) 4 (57.1%)
College 13 (46.4%) 6 (54.5%) 5 (50%) 2 (28.6%)
Employment
Full-time 18 (64.3%) 9 (81.8%) 5 (50%) 4 (57.1%)
Part-time 7 (25%) 0 4 (40%) 3 (42.9%)
Retired 3 (10.7%) 2 (18.2%) 1 (10%) 0
Economic status
<30k 14 (50%) 5 (36%) 6 (60%) 3 (42.9%)
30–60k 9 (33.3%) 3 (40%) 3 (30%) 3 (42.9%)
60–100k 3 (11.6%) 2 (20%) 0 1 (14.2%)
>100k 2 (5.1%) 1 (4%) 1 (10%) 0
IBS subgroups
IBS-constipation 8 (35.9%) 3 (27.3%) 3 (30%) 2 (28.6%)
IBS-diarrhea 10 (29.5%) 5 (45.4%) 3 (30%) 2 (28.6%)
IBS-mixed 10 (34.6%) 3 (27.3%) 4 (40%) 3 (42.9%)
Percent in parentheses represent value of the total in a given category.
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[258_TD$DIFF]scale (HADS), IBS-global assessments of improvement (IBS-GAI),
autonomic symptom score
There were signiﬁcant improvements in all the secondary
outcomes, HADS, Autonomic Symptom score, [234_TD$DIFF]and IBS-GAI, at week
12 and week 24 when compared to week 0 (p<0.001). The
improvements were sustained in all the secondary outcome
assessments from week 12 to week 24, and in IBS-GAI, there was
signiﬁcant further improvement (p<0.05) (Fig. 4).[(Fig._3)TD$FIG]
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Fig. 3. Changes in the primary outcomes in IBS patients enrolled in the follow-up group.
analyzed using repeatedmeasures [175_TD$DIFF]ANOVA followed by Post hoc [174_TD$DIFF]analysis with Bonferroni [176_TD$DIFF]c
to week 0; [177_TD$DIFF]***p<0.001; x: Represents signiﬁcant changes at week 24 when compared3.4.1. Medicine and supplement use.
At the baseline appraisal, 21 out of the 28 subjects in the
Follow-up group reported medicine and supplement use and
seven subjects did not use any medication/supplements. Most
commonly used medication/supplements were dicyclomine,
bentyl, amitiza, linzess, loperamide, psyllium, ﬁber drinks, herbal
teas [260_TD$DIFF], and probiotics. There were signiﬁcant improvements in the
medicine and supplement use at week 12 and week 24 (p<0.001)
when compared to week 0 (Supplement Table 3), and the
improvements were sustained from week 12 to week 24. All 21IBS-QOL
Week 0
Week 12
Week 24
*** ***
IBS-SSS and IBS-QOL at week 12 and week 24 when compared to week 0. Data were
orrection. *: Represents signiﬁcant changes atweek 12 andweek 24when compared
to week 12; xxp<0.01.
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Fig. 4. Changes in the secondary outcomes in IBS patients enrolled in the follow-up group. HADS-anxiety, HADS-depression, autonomic symptom score, and IBS-GAI at week
12 and week 24 when compared to week 0. Data were analyzed using repeated measures of ANOVA followed by Post hoc [174_TD$DIFF]analysis with Bonferroni [178_TD$DIFF]correction. *: Represents
signiﬁcant changes at week 12 and week 24 when compared to week 0; ***p<0.001; x: Represents signiﬁcant changes at week 24 when compared to week 12; xp<0.05.
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at week 12, and at week 24, 20 patients reported to have stopped
all medicine/supplement use. Only one patient was on reduced
medication at the end of week 24.
3.5. Measurements
3.5.1. BMI and physical ﬂexibility
There was a reduction in BMI at week 24 (from 27.145.28 to
26.715.08; p<0.05) when compared to week [262_TD$DIFF]0, which was not
observed at week 12. Hip-trunk ﬂexibility improved from week 0
(21.328.03) to week 12 (28.117.43; p<0.001) [263_TD$DIFF]to week 24
(29.547.57; p<0.001). Left and right shoulder ﬂexibility[(Fig._5)TD$FIG]
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Fig. 5. Changes in heart rate variability in IBS patients enrolled in Follow-up group. Freq
Data were analyzed using repeated measures of ANOVA followed by Post hoc [174_TD$DIFF]analysis w
changes at week 12 and week 24 when compared to week 0; **p<0.01; ***p<0.001; ximproved signiﬁcantly at week 12 when compared to week 0
with further improvements at week 24 (data not shown).
3.6. Autonomic changes
3.6.1. Sympathetic reactivity tasks
The handgrip strength (handgrip task) [264_TD$DIFF]improved signiﬁcantly
from week 0 (35.6812.29) to week 12 (42.6111.7; p<0.001)
and week 24 (46.0711.9; p<0.001). In the mental arithmetic
task, speed improved from 37.9321.33 at week 0 to 51.3927.63
at week 12 (p<0.01) and continued to improve at week 24
(57.8632.96; p<0.001) when compared to week 0. [266_TD$DIFF] n addition,
there was a signiﬁcant improvement in the accuracy from week 0F HF
Week 0
Week 12
Week 24
*** **
§
uency domain during deep breathing at week 12 and week 24 compared to week 0.
ith Bonferroni correction. ms2: milliseconds per square; *: Represents signiﬁcant
: [179_TD$DIFF]Represents signiﬁcant changes at week 24 when compared to week 12; xp<0.05.
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(55.1834.15; p<0.001).
Although there were no signiﬁcant improvements in the
diastolic blood pressure during the handgrip task, a trend of
lowered diastolic blood pressure was observed. A similar trend of
lowered systolic and diastolic blood pressure was observed in the
mental arithmetic task. Therewere no changes in heart rate during
this task (data not shown).
3.6.2. Parasympathetic reactivity tasks
There were signiﬁcant improvements in the frequency
domain of heart rate variability during deep-breathing task from
week 0 to week 24, but not from week 0 to week 12. There was a
signiﬁcant reduction in LF (p<0.001) fromweek 0 to week [267_TD$DIFF] 4, but
most of the improvement was seen fromweek 12 toweek 24. Even
though HF increased signiﬁcantly (p<0.01) fromweek 0 to week [267_TD$DIFF]
24, most of the improvement (a 27% increase (p<0.05)) was
observed from week 12 to week 24 (Fig. 5). In the LF/HF ratio, an
indicator of parasympathetic activity, there was a trend of
improvement at week 12, whereas signiﬁcant improvements
(p<0.01) were seen at week 24, when compared to week 0 [271_TD$DIFF](data
not shown).
In the second parasympathetic task of supine to upright posture
(30–15 ratio), a trend of improvement was observed at week 12, [272_TD$DIFF]
and this was signiﬁcantly improved (p<0.01) at week 24 when
compared to week 0. The parasympathetic dominance in this task
had improved signiﬁcantly from week 12 to week 24 (p<0.05)
(Table 3).
4. Discussion
The results reported in the present study provide encouraging
evidence that the main ﬁndings of our RYM (three times a week
for 12 weeks) analyses (Phase 1) are replicable (WL-Yoga group)
and can be sustained during the long-term (Follow-up group)
with one hour supervised RYM practices, once a week for 12
more weeks.
The clinical signiﬁcance of improvements observed in the two
primary outcome assessments is [274_TD$DIFF]substantial. At week 12, reduction
in IBS-SSS was 195 points relative toweek 0, which is substantially
higher than the 50 point reduction [275_TD$DIFF]that is considered to be
clinically signiﬁcant improvement [4]. The consequent improve-
ment at week 24 (follow-up) was even superior [276_TD$DIFF]with an
improvement of 230 points. The improvements in IBS-QOL at
week 12 was 26 points compared to week 0, which [277_TD$DIFF]is signiﬁcantly
higher than the 14 point gain to be considered clinically improved
[6].
The results of the WL-Yoga group after 12 weeks of RYM
interventionwere parallel with those of the Yoga and Combination
groups in the primary outcomes of IBS-SSS and IBS-QOL and
secondary outcomes of anxiety, depression, medicine and supple-
ment use, and GAI (Phase 1). The non-signiﬁcant changes observed
in physical ﬂexibility and autonomic tasks could be due to the
reduced number of sessions attended by this group. These results
could suggest that regular practice of RYM is essential to bring
about signiﬁcant changes.Table 3
Comparison of supine to upright posture (30–15 ratio) in the follow-up group IBS pati
Week 0 95% CI Week 12
30–15 ratio 1.0770.05 1.05, 1.09 1.1020.07
Datawere analyzed using repeatedmeasures of ANOVA followed by Post hoc analysis with
compared toweek 0; [%]: percentage changewhen compared toweek 12; [183_TD$DIFF]*: Represents ch
changes when compared to week 12; x: p<0.05.The present follow-up study has shown improvements across
all groups, which is in contrast to previous Yoga investigations on
IBS [7]. The Global Assessment of Improvement is signiﬁcantly
higher than that reported in recent Yoga study (follow-up) carried
out on adolescents and young adults [8]. Our results are analogous
to several studies that have reported that Yoga reduces the
medication usage [9–11]. Almost all the patients were able to stop
using prescription/non prescription medicines and supplements
for their IBS symptoms [283_TD$DIFF]. However, one patient reported using
prescription medication at a reduced level, once every other day.
Improved hip-trunk and shoulder ﬂexibility ﬁndings of this study
concur with a previous investigation [12]. The reported results of
BMI in this study are in [285_TD$DIFF]agreement with a survey that reported
long-term Yoga practitioners had reduced BMI [10].
Similar to what was observed in the present study, a previous
study reported [286_TD$DIFF]that a 6-month Yoga program had increased hand
grip strength [13]. Our results of signiﬁcant improvements in
mental arithmetic task (accuracy and speed) [287_TD$DIFF]are concurrent with
the observation by Nagendra et al. [14]. The signiﬁcant changes in
heart-rate and blood pressure in healthy adults reported by Indla
and Narhare [15] were not replicated in the present study, which
could be due to unhealthy subjects (IBS), but a trend of lowered
heart rate and blood pressure was observed. Our results of
parasympathetic dominance in deep breathing (frequency do-
main) and supine to upright posture (30:15) extend support to
observations of other Yoga investigations [11,14,16].
The beneﬁts of RYM intervention enjoyed by the IBS patients in
our study are far reaching. Patients self-reported that Yoga had
helped in relieving other health issues that they suffered from,
such as headaches, arthritis, and inﬂexibility. In addition, Yoga
helped them regain positivity, calmness, and energy, as well as
made them feel more relaxed in stressful situations. Yoga therapy
reportedly helped them regain control of their lives from IBS, and
they now feel that IBS has little effect on their quality of life. The
patients felt completely revitalized with the Yoga therapy and
planned to continue practicing Yoga regularly (Supplement
Table 4). There were no adverse events reported in the Follow-
up group.
The limitations of this replication and follow-up study include a
high dropout rate in theWL-Yoga [294_TD$DIFF]and follow-up groups. This could
be due to the fact that the working adult population in this study
could not allocate extra time for the intervention (in addition to 12
weeks of waiting period) because of conﬂicts in work schedules,
children’s after school activities [295_TD$DIFF], or other family matters. The
number of Follow-up group patients (n =28) was small compared
to initial numbers of 58 that completed the ﬁrst 12-week RYM
intervention. This could be due to our exclusion [296_TD$DIFF]criterion of ‘no
practice of Yoga at home.’ Time constraints and practicing at
home were mentioned by patients for not being able to continue
with the follow-up intervention. Another limitation was lack of a
control group to compare the results of a weekly one-hour of RYM
session.
In conclusion, our study provides [297_TD$DIFF]potential evidence for the
continuation and replication of RYM’s effects on IBS. More rigorous
and longer-term trials with larger sample size are warranted to
strengthen the efﬁcacy of RYM for IBS [298_TD$DIFF]that was seen in the presentents at week 12 and week 24 with week 0.
95% CI Week 24 95% CI
1.07, 1.12 1.1480.08**x (6.59%) [4.17%] 1.11, 1.18
Bonferroni [178_TD$DIFF]correction. Values are groupmeans S.D. (%): percentage changewhen
anges atweek 12 andweek 24when compared toweek 0; **: p<0.01; x: [179_TD$DIFF]Represents
616 V. Kavuri et al. / European Journal of Integrative Medicine 7 (2015) 609–616study. With the results presented, it can be concluded that RYM
alone or RYM combined with conventional care as implemented [299_TD$DIFF]in
the present study could be a safe, efﬁcient [300_TD$DIFF], and long-term solution
for IBS symptoms. A group setting with personalized attention
given by the instructor could be a motivating factor for patients to
adhere to such [301_TD$DIFF]physical activity programs.
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